Walleye Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Sell
3,500
-3,500
-50% -$1.04M ﹤0.01% 2045
2025
Q4
$1.91M Sell
7,000
-18,200
-72% -$4.95M 0.01% 1911
2025
Q3
$6.81M Buy
25,200
+14,300
+131% +$3.89M 0.03% 740
2025
Q2
$3M Buy
10,900
+3,100
+40% +$843K 0.01% 1207
2025
Q1
$2.07M Sell
7,800
-23,000
-75% -$5.67M 0.01% 1395
2024
Q4
$7.15M Sell
30,800
-11,300
-27% -$2.6M 0.02% 846
2024
Q3
$9.29M Buy
42,100
+600
+1% +$124K 0.02% 734
2024
Q2
$8.16M Sell
41,500
-9,700
-19% -$2M 0.01% 908
2024
Q1
$11M Sell
51,200
-2,100
-4% -$441K 0.02% 773
2023
Q4
$11.2M Sell
53,300
-7,200
-12% -$1.54M 0.02% 613
2023
Q3
$12.1M Buy
60,500
+53,900
+817% +$10.7M 0.03% 469
2023
Q2
$1.22M Buy
6,600
+5,100
+340% +$943K ﹤0.01% 1685
2023
Q1
$287K Buy
+1,500
New +$271K ﹤0.01% 2172
2020
Q1
Sell
-2,300
Closed -$462K 1030
2019
Q4
$462K Hold
2,300
0.03% 704
2019
Q3
$486K Buy
+2,300
New +$481K 0.03% 768

Other funds holding CME

Walleye Capital's CME Position: Q1 2026 in Review

Walleye Capital increased its CME Group (CME) stake by 57,559% in Q1 2026, buying an estimated $19.3M and bringing the position to 65,155 shares worth $19.2M. The position accounts for 0.08% of the portfolio, ranked #204.

Walleye Capital first reported a position in CME in Q3 2018 and has held it in 18 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Walleye Capital held 65,155 shares of CME Group worth $19.2M as of Q1 2026.
  • Walleye Capital bought 65,042 CME Group shares in Q1 2026, an estimated $19.3M.
  • CME Group made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #204 holding.
  • Walleye Capital first reported a position in CME Group in Q3 2018 and has held it in 18 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.